Sort

Search

01/06/2024 Healthcare and Epidemiological Surveillance Costs of Hepatitis A Outbreaks in Spain in Regions with and without Universal Hepatitis A Vaccination of Children during 2010-2018
Plans-Rubió, P, Pericas, C, Avellon, AM, Izquierdo, C, Martínez, A, Torner, N, Martínez, A, Borras, E, Roig, F, Godoy, P, Rius, C. Healthcare and Epidemiological Surveillance Costs of Hepatitis A Outbreaks in Spain in Regions with and without Universal Hepatitis A Vaccination of Children during 2010-2018. Vaccines. 2024; 12(6)DOI:10.3390/vaccines12060648. PMID:38932377. IF:3.400(Q2/4D).
01/06/2024 Early cardiac function in women with and without high-risk of preeclampsia
Ullmo, J, Cruz-Lemini, M, Lidia, B, Mireia, P, Barbarà, MC, Martorell, S, Clivillé, DB, Gallardo, CD, Gimenez, CG, Trilla, C, García, OS, Costa, FC, Sionis, A, Mora, J, Osuna, AG, Ordoñez, J, Llurba, E. Early cardiac function in women with and without high-risk of preeclampsia. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION. 2024; 54DOI:. PMID:. IF:3.600(Q1/2D).
01/06/2024 A Mild Presentation of X-Linked Hypophosphatemia Caused by a Non-Canonical Splice Site Variant in the PHEX Gene
Fraga, G, Herreros, MA, Pybus, M, Aza-Carmona, M, Pilco-Teran, M, Furlano, M, García-Borau, MJ, Torra, R, Ars, E. A Mild Presentation of X-Linked Hypophosphatemia Caused by a Non-Canonical Splice Site Variant in the PHEX Gene. Genes. 2024; 15(6)DOI:10.3390/genes15060679. PMID:38927615. IF:2.800(Q2/5D).
01/06/2024 Use of Eculizumab in Pediatric Patients with High-Risk Transplantation-Associated Thrombotic Microangiopathy: Outcomes and Risk Factors Associated with Response and Survival. A Retrospective Study on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC)
Carabante, MIB, Bueno, D, García, LA, Torija, IL, Marsal, J, Navarro, JMF, Oficialdegui, MLU, Panesso, M, Molina, B, Bieler, CB, Palomo, P, Martinez, AP, Diaz-de-Heredia, C. Use of Eculizumab in Pediatric Patients with High-Risk Transplantation-Associated Thrombotic Microangiopathy: Outcomes and Risk Factors Associated with Response and Survival. A Retrospective Study on Behalf of the Spanish Group for Hematopoietic Transplantation and Cellular Therapy (GETH-TC). Transplantation And Cellular Therapy. 2024; 30(6)DOI:10.1016/j.jtct.2024.03.019. PMID:38521410. IF:4.400(Q1/1D).